rs786201037
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001166114.2(PNPLA6):c.3266G>A(p.Arg1089Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001166114.2 missense
Scores
Clinical Significance
Conservation
Publications
- ataxia-hypogonadism-choroidal dystrophy syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- PNPLA6-related spastic paraplegia with or without ataxiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 39Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- cerebellar ataxia-hypogonadism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Laurence-Moon syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- trichomegaly-retina pigmentary degeneration-dwarfism syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PNPLA6 | NM_001166114.2 | c.3266G>A | p.Arg1089Gln | missense_variant | Exon 26 of 32 | ENST00000600737.6 | NP_001159586.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PNPLA6 | ENST00000600737.6 | c.3266G>A | p.Arg1089Gln | missense_variant | Exon 26 of 32 | 1 | NM_001166114.2 | ENSP00000473211.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461128Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726948 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome Pathogenic:1
- -
not provided Pathogenic:1
- -
Hereditary spastic paraplegia 39 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PNPLA6 function (PMID: 25480986, 31780887). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PNPLA6 protein function. ClinVar contains an entry for this variant (Variation ID: 183693). This variant is also known as p.Arg1099Gln. This missense change has been observed in individual(s) with Oliver-McFarlane syndrome (PMID: 25480986). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1051 of the PNPLA6 protein (p.Arg1051Gln). -
Ataxia-hypogonadism-choroidal dystrophy syndrome Other:1
To date reported only in compound heterozygotes with Oliver-McFarlane syndrome -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at